In recent trading session, Relmada Therapeutics Inc (NASDAQ:RLMD) saw 0.6 million shares changing hands at last check today with its beta currently measuring 0.26. Company’s
In the last trading session, 0.74 million shares of the Relmada Therapeutics Inc (NASDAQ:RLMD) were traded, and its beta was 0.14. Most recently the company’s
In the last trading session, 1.2 million shares of the Relmada Therapeutics Inc (NASDAQ:RLMD) were traded, and its beta was 0.15. Most recently the company’s
Relmada Therapeutics Inc (NASDAQ:RLMD)’s traded shares stood at 2.1 million during the last session, with the company’s beta value hitting 0.18. At the close of
In the last trading session, 1.81 million Relmada Therapeutics Inc (NASDAQ:RLMD) shares changed hands as the company’s beta touched -0.26. With the company’s per share
In last trading session, Relmada Therapeutics Inc (NASDAQ:RLMD) saw 32.59 million shares changing hands with its beta currently measuring -0.02. Company’s recent per share price
Relmada Therapeutics Inc (NASDAQ:RLMD) has a beta value of 0.15 and has seen 0.42 million shares traded in the recent trading session. The company, currently
In last trading session, Relmada Therapeutics Inc (NASDAQ:RLMD) saw 0.38 million shares changing hands with its beta currently measuring 0.19. Company’s recent per share price
During the last session, Relmada Therapeutics Inc (NASDAQ:RLMD)’s traded shares were 0.67 million, with the beta value of the company hitting 0.38. The 52-week high
In today’s recent session, 0.59 million shares of the Relmada Therapeutics Inc (NASDAQ:RLMD) have been traded, and its beta is 0.39. Most recently the company’s
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
